Related Experiment Video
Updated: May 18, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Selection of possible responders to thrombolytic therapy in acute ischemic stroke
Christian Hametner1, Peter Arthur Ringleb, Werner Hacke
1Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Ischemic stroke is one of the leading causes of death and morbidity worldwide, and systemic thrombolytic treatment is still the first-line therapy within 4.5 h from symptom onset. Selecting patients for treatment response is mandatory in any time window but challenging as well. The authors aim to support stroke physicians in their individual decision making. Besides evidence from clinical trials, some suggestions included here exclusively reflect the authors' opinions. This article presents clinical and imaging criteria of selecting patients reasonably, offering causal therapy to a growing number of patients.
Ischemic stroke is one of the leading causes of death and morbidity worldwide, and systemic thrombolytic treatment is still the first-line therapy within 4.5 h from symptom onset. Selecting patients for treatment response is mandatory in any time window but challenging as well. The authors aim to support stroke physicians in their individual decision making. Besides evidence from clinical trials, some suggestions included here exclusively reflect the authors' opinions. This article presents clinical and imaging criteria of selecting patients reasonably, offering causal therapy to a growing number of patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Acute Coronary Syndrome I: Introduction

